Thrombosis
Thrombosis
Advertisement
Andrew MorenoPolycythemia Vera | March 19, 2025
Thrombosis history was not predictive of overall survival in patients with pulmonary hypertension risk and PV, a study found.
Andrew MorenoThrombosis | March 12, 2025
In findings arterial thrombosis carried worse overall survival than venous thrombosis in this patient population.
Anthony Sochet, MD, MSThrombosis | March 4, 2025
Clinical data is limited in areas such as how to evaluate bleeding risk and when to apply mechanical thromboprophylaxis.
Andrew MorenoThrombosis | January 29, 2025
The new agent is on the 505(b)(2) regulatory pathway and was compared with tablet-form apixaban in 60 healthy volunteers.
Patrick DalyThrombosis | March 21, 2024
VRd was associated with lower rates of venous thromboembolism versus KRd in patients with newly-diagnosed multiple myeloma.
Patrick DalyThrombosis | January 10, 2024
Intracardiac thrombosis in patients with COVID-19 was associated with increased all-cause and cardiovascular mortality.
Patrick DalyVTE | November 8, 2023
Patients treated for isolated superficial vein thrombosis with anticoagulants still had a "substantial" risk of VTE later on.
Patrick DalyThrombosis | November 8, 2023
Splenomegaly and myeloproliferative disorders increased risk for porto-spleno-mesenteric venous thrombosis after splenectomy.
Patrick DalyThrombosis | October 25, 2023
Edoxaban therapy for 12 months was superior to three-month therapy for preventing venous thromboembolisms and related deaths.
Patrick DalyThrombosis | February 16, 2024
Subclinical leaflet thrombosis appears more common after TAVR versus SAVR, but was not associated with increased stroke risk.
Hady Lichaa, MDThrombosis | January 25, 2023
In the second half of a two-part interview, DocWire News partner Hady Lichaa, MD, FACC, FSCAI, FSVM, RPVI, spoke with ...
Hady Lichaa, MDThrombosis | January 24, 2023
In part one of a two-part interview, DocWire News partner Hady Lichaa, MD, FACC, FSCAI, FSVM, RPVI, sits down with ...
CardioNerdsCardioNerds | September 6, 2023
It’s another session of CardioNerds Rounds! In these rounds, Dr. Priya Kothapalli (Interventional FIT at University of ...
Rob DillardThrombosis | September 6, 2023
DocWire News recently spoke with Dan Bloomfield, MD, FACC, FAHA, Chief Medical Officer of Anthos Therapeutics. Dr. ...
Patrick DalyKidney Transplantation | February 5, 2024
Researchers assessed the UK experience of kidney transplantations from deceased donors who had vaccine-induced immune ...
Patrick DalyITP | September 6, 2023
In a study in Research and Practice in Thrombosis and Haemostasis, researchers examined changes in clinical and platelet ...
Patrick DalyAtrial Fibrillation | September 11, 2023
Therapies that can reduce risk of thrombosis without increasing bleeding complications are needed to improve stroke ...
Patrick DalyVTE | September 6, 2023
Apixaban has been shown to be effective for preventing venous thromboembolism (VTE) in patients with cancer, but is ...
Rob DillardThrombosis | February 3, 2022
Recently, the CHEETAH study (initiated in 2019), the first large study to demonstrate the safety ...
DocWire News EditorsNephrology Times | February 5, 2024
Nephrotic-range proteinuria is a common reason for nephrological consultation. However, the differential diagnosis is ...
Advertisement